NEOS Investment Management’s ResMed RMD Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$4.6M Buy
23,606
+2,887
+14% +$598K 0.02% 380
2026
Q1
$4.65M Buy
20,719
+4,706
+29% +$1.17M 0.02% 345
2025
Q4
$3.86M Buy
16,013
+2,474
+18% +$633K 0.02% 371
2025
Q3
$3.71M Buy
13,539
+4,461
+49% +$1.22M 0.03% 349
2025
Q2
$2.34M Buy
9,078
+1,786
+24% +$426K 0.03% 345
2025
Q1
$1.63M Buy
7,292
+1,253
+21% +$293K 0.03% 360
2024
Q4
$1.38M Buy
6,039
+1,238
+26% +$298K 0.03% 347
2024
Q3
$1.17M Buy
4,801
+812
+20% +$181K 0.04% 344
2024
Q2
$764K Buy
3,989
+996
+33% +$202K 0.03% 369
2024
Q1
$593K Buy
2,993
+905
+43% +$166K 0.04% 347
2023
Q4
$359K Buy
2,088
+596
+40% +$91.6K 0.03% 343
2023
Q3
$221K Buy
+1,492
New +$270K 0.03% 336

Other funds holding RMD

NEOS Investment Management's RMD Position: Q2 2026 in Review

NEOS Investment Management increased its ResMed (RMD) stake by 14% in Q2 2026, buying an estimated $598K and bringing the position to 23,606 shares worth $4.6M. The position accounts for 0.02% of the portfolio, ranked #380.

NEOS Investment Management first reported a position in RMD in Q3 2023 and has held it in 12 quarters since. The position peaked at $4.65M in Q1 2026. 889 funds tracked by Wall St. Rank hold RMD as of Q2 2026.

  • NEOS Investment Management held 23,606 shares of ResMed worth $4.6M as of Q2 2026.
  • NEOS Investment Management bought 2,887 ResMed shares in Q2 2026, an estimated $598K.
  • ResMed made up 0.02% of NEOS Investment Management's portfolio in Q2 2026, its #380 holding.
  • NEOS Investment Management first reported a position in ResMed in Q3 2023 and has held it in 12 quarters since.
  • NEOS Investment Management's ResMed position peaked at $4.65M in Q1 2026.
  • 889 funds tracked by Wall St. Rank held ResMed as of Q2 2026.

Based on NEOS Investment Management's 13F filing for Q2 2026, filed 11 Aug 2026.